Sunday, November 30, 2014

New active substance effectively combats Philadelphia chromosome-positive leukaemia

›
New active substance effectively combats Philadelphia chromosome-positive leukaemia
Friday, November 28, 2014

Bacterial protein flagellin can prevent and cure rotavirus infection

›
Activation of the innate immune system with the bacterial protein flagellin could prevent and cure rotavirus infection, which is among th...
Thursday, November 27, 2014

Smart drug Modafinil can impair cognitive performance in healthy students

›
It is claimed one in five students have taken the 'smart' drug Modafinil to boost their ability to study and improve their chance...
Wednesday, November 26, 2014

Breakthrough in flexible electronics enabled by inorganic-based laser lift-off

›
A research team led by Prof. Keon Jae Lee of KAIST provides an easier methodology  to  realize  high  performance flexible electronics...

Chaetocin synergistic with TKIs against CML cells

›
Chaetocin (structure below), a mycotoxin that increases oxidative stress, can complement the activity of tyrosine kinase inhibitors (TKIs)...
Tuesday, November 25, 2014

Isis Pharmaceuticals announces initiation of ISIS-SMN Rx Phase 3 study in children with SMA

›
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced  the initiation of a pivotal Phase 3 study evaluating ISIS-SMN Rx  in approximately 120 ...

University of Leeds researchers make new synthetic anti-cancer molecule

›
Researchers at the University of Leeds have made a new synthetic anti-cancer molecule that targets two key mechanisms in the spread of mal...
Monday, November 24, 2014

New drug combination shows promise as effective, safe treatment for rheumatoid arthritis

›
A new drug combination for rheumatoid arthritis treats the disease just as well as other intensive treatment strategies but with less medi...
4 comments:
Friday, November 21, 2014

Sulindac drug can protect against oxidative damage due to AMD

›
In continuation of my update on Sulindac Scientists at Florida Atlantic University's Charles E. Schmidt College of Science, as wel...

FDA Approves Olysio (simeprevir) in Combination with Sofosbuvir for Genotype 1 Chronic Hepatitis C Infection

›
In continuation of my update on sofosbuvir Janssen Therapeutics, Division of Janssen Products, LP (Janssen) announced the U.S. Food ...
Thursday, November 20, 2014

New treatment regimen for hepatitis C in transplant patients produces promising results

›
The investigational three-drug regimen, which produced hepatitis C cure rates of 97 percent, is an oral interferon-free therapy. Previou...
Wednesday, November 19, 2014

Study reports anti-cancer activity in mice treated with experimental drug TAK-733

›
Study reports anti-cancer activity in mice treated with experimental drug TAK-733 TAK-733 is a potent and selective MEK allosteric sit...
Tuesday, November 18, 2014

Eribulin drug has minor added benefit in one patient group, indication of lesser benefit in others

›
In continuation of my update on  Eribulin Eribulin (trade name: Halaven) is approved for women with locally advanced or metastatic br...
Monday, November 17, 2014

FDA Approves Dual-Chamber Syringe for Abilify Maintena (aripiprazole) for Schizophrenia

›
In continuation of my update on  aripiprazole We know that,  Aripiprazole  ( brand names:   Abilify ,   Aripiprex ) is a   atypical ...
Friday, November 14, 2014

FDA Approves Ofev (nintedanib) for Idiopathic Pulmonary Fibrosis

›
In continuation of update on  nintedanib The U.S. Food and Drug Administration today approved  Ofev  (nintedanib) for the treatment of...